Copyright
©The Author(s) 2023.
World J Gastroenterol. Apr 14, 2023; 29(14): 2188-2201
Published online Apr 14, 2023. doi: 10.3748/wjg.v29.i14.2188
Published online Apr 14, 2023. doi: 10.3748/wjg.v29.i14.2188
HBV (n = 1064) | HCV (n = 507) | NBNC (n = 391) | P value | Missing rate | |
Demographics | |||||
Age (yr) | 52.05 ± 10.90 | 58.69 ± 10.84 | 51.97 ± 13.10 | < 0.0001 (2 & 3, 1 & 2) | 0.00% |
Male sex, n (%) | 825 (77.5) | 273 (53.8) | 233 (59.6) | < 0.0001 | 0.00% |
Weight (kg) | 68.36 ± 12.30 | 64.53 ± 12.17 | 70.94 ± 14.09 | < 0.0001 (2 & 3, 1 & 2, 1 & 3) | 0.97% |
Height (cm) | 166.34 ± 7.62 | 161.67 ± 8.57 | 164.18 ± 8.75 | < 0.0001 (2 & 3, 1 & 2, 1 & 3) | 2.80% |
BMI (kg/m2) | 24.66 ± 3.62 | 24.58 ± 3.75 | 26.25 ± 4.23 | < 0.0001 (2 & 3, 1 & 3) | 3.47% |
Lab data at ARFI study | |||||
Spleen index (cm2) | 31.97 ± 14.47 | 33.63 ± 16.72 | 34.07 ± 16.05 | 0.0640 (1 & 3) | 0.03% |
Albumin (mg/dL) | 4.345 ± 0.51 | 4.29 ± 0.51 | 4.43 ± 0.48 | 0.0040 (2 & 3) | 42.15% |
AST (U/L) | 57.50 ± 102.16 | 62.46 ± 58.08 | 58.40 ± 50.72 | 1.12% | |
ALT (U/L) | 75.05 ± 162.88 | 71.52 ± 69.61 | 83.46 ± 78.32 | 1.33% | |
Bilirubin (mg/dL) | 0.93 ± 1.23 | 0.91 ± 1.19 | 0.92 ± 1.21 | 12.79% | |
Prothrombin time (INR) | 1.10 ± 0.13 | 1.11 ± 0.21 | 1.06 ± 0.13 | 0.0040 (2 & 3, 1 & 3) | 42.15% |
Platelets (109/L) | 177.86 ± 61.86 | 170.13 ± 60.19 | 218.96 ± 76.08 | < 0.0001 (2 & 3, 1 & 3) | 13.25% |
FIB4 | 2.454 ± 2.720 | 3.31 ± 3.04 | 2.06 ± 2.13 | < 0.0001 (2 & 3, 1 & 2) | 23.35% |
Mean ARFI (m/s)1 | 1.40 ± 0.46 | 1.60 ± 0.61 | 1.42 ± 0.62 | < 0.0001 (2 & 3, 1 & 2) | 0.00% |
Stiffness status1 | < 0.0001 | ||||
Cirrhosis | 331 (31.1) | 163 (32.1) | 78 (19.9) | ||
Severe fibrosis | 138 (13.0) | 110 (21.7) | 61 (15.6) | ||
Moderate fibrosis | 114 (10.7) | 68 (13.4) | 29 (7.4) | ||
Mild or non-fibrosis | 481(45.2) | 166(32.7) | 223(57.0) | ||
Comorbidities | |||||
Hypertension | 181 (17.0) | 147 (29.0) | 115 (29.4) | < 0.0001 | |
Diabetes | 119 (11.2) | 103 (20.3) | 76 (19.4) | < 0.0001 | |
Heart failure | 14 (1.3) | 17 (3.4) | 7 (1.8) | 0.023 | |
Atrial fibrillation | 9 (0.8) | 11 (2.2) | 5 (1.3) | 0.091 | |
Myocardial infraction | 12 (1.1) | 5 (1.0) | 2 (0.5) | 0.567 | |
Ischemic stroke | 6 (0.6) | 17 (3.4) | 8 (2.0) | < 0.0001 | |
Dyslipidemia | 170 (16.0) | 95 (18.7) | 125 (32.0) | < 0.0001 | |
Follow-up (year) | |||||
mean ± SD | 4.59 ± 2.22 | 4.34 ± 2.35 | 3.13 ± 2.15 | < 0.0001 (1 & 3, 2 & 3) | |
Median/IQR | 4.54/3.59 | 3.97/3.88 | 2.61/3.23 |
- Citation: Tai J, Harrison AP, Chen HM, Hsu CY, Hsu TH, Chen CJ, Jeng WJ, Chang ML, Lu L, Tai DI. Acoustic radiation force impulse predicts long-term outcomes in a large-scale cohort: High liver cancer, low comorbidity in hepatitis B virus. World J Gastroenterol 2023; 29(14): 2188-2201
- URL: https://www.wjgnet.com/1007-9327/full/v29/i14/2188.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i14.2188